dorsaVi Pty Ltd MDMV6B 사용자 설명서
ViMove v6 User Manual | ©dorsaVi USA, Inc. | Rev. 20170203
3
•
In order to reduce the risk of skin irritation, it is advised not to wear the sensors for any
more than 24 hours in any 72 hour period.
•
There is the potential for patient injury or re-injury if there is a function failure and the
device fails to alert the patient of risk related movements. To prevent this, the device has
been programmed to alert the patient if a signal loss or other malfunction occurs. Ensure the
patient is informed of these features and are aware they will not be receiving Biofeedback if
one of these warnings is shown.
•
Use only with supplied power supply.
•
Recording and Feedback Device (RFD) Battery: As with all batteries, there is a risk of battery
leakage or explosion; however, the manufacturer of the RFD battery has conducted safety
tests, heating the batteries to 130°C for ten minutes with no rupture, no fire, bursting or
explosion. In addition, the battery is housed in the sealed, splash resistant RFD unit.
•
Do not clean the equipment with Acetone. Use alcohol wipes for cleaning.
•
Do not immerse any components of the device in water or any other liquid substance.
•
Use of any equipment should be immediately terminated upon any sign of treatment-
related distress or discomfort.
•
Not to be connected to a patient undergoing MRI (Magnetic Resonance Imaging), Electro
surgery or defibrillation.
•
Operations in close proximity to shortwave or microwave therapy equipment may produce
instability in the output.
•
Do not operate the device within 10 feet of powerful radio interference producing sources
such as arc welders, radio thermal treatment equipment, x-ray machines, or any other
equipment that produces electrical sparks. Portable and mobile RF communication
equipment may also affect this equipment.
•
Radiated radio frequency electromagnetic fields can cause performance degradation in
ViMove.
•
After use, the Disposable Application Pads (DAPs) may be a biohazard. Following use,
dispose of these materials in accordance with accepted medical practice and any applicable
local, state and federal laws and regulations.
•
The operator is responsible for ensuring the safety of any devices controlled or triggered by
ViMove equipment or software, or by any software or hardware receiving data from
equipment. dorsaVi USA, Inc. equipment must not be configured or connected in such a way
that failure in its data acquisition, processing or control functions can trigger patient
feedback stimulus that poses an unacceptable level of risk.
•
Between uses of the device, wipe down components with alcohol wipes or swabs.
1.6 Adverse Reactions
The potential adverse reactions that may be experienced with the use of the device include:
Skin irritation beneath the adhesive pads and / or electrodes (DAPs).